INBX
Price
$13.38
Change
+$0.49 (+3.80%)
Updated
Jun 6, 10:36 AM (EDT)
Capitalization
186.59M
74 days until earnings call
SRZN
Price
$8.70
Change
+$0.06 (+0.69%)
Updated
Jun 6, 10:30 AM (EDT)
Capitalization
73.98M
Interact to see
Advertisement

INBX vs SRZN

Header iconINBX vs SRZN Comparison
Open Charts INBX vs SRZNBanner chart's image
Inhibrx Biosciences
Price$13.38
Change+$0.49 (+3.80%)
Volume$100
Capitalization186.59M
Surrozen
Price$8.70
Change+$0.06 (+0.69%)
VolumeN/A
Capitalization73.98M
INBX vs SRZN Comparison Chart
Loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INBX vs. SRZN commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Hold and SRZN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (INBX: $12.89 vs. SRZN: $8.64)
Brand notoriety: INBX and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 48% vs. SRZN: 42%
Market capitalization -- INBX: $186.59M vs. SRZN: $73.98M
INBX [@Biotechnology] is valued at $186.59M. SRZN’s [@Biotechnology] market capitalization is $73.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 2 FA rating(s) are green whileSRZN’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 2 green, 3 red.
  • SRZN’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than SRZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 5 TA indicator(s) are bullish while SRZN’s TA Score has 5 bullish TA indicator(s).

  • INBX’s TA Score: 5 bullish, 3 bearish.
  • SRZN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INBX is a better buy in the short-term than SRZN.

Price Growth

INBX (@Biotechnology) experienced а -6.25% price change this week, while SRZN (@Biotechnology) price change was +1.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.36%. For the same industry, the average monthly price growth was +17.11%, and the average quarterly price growth was +3.22%.

Reported Earning Dates

INBX is expected to report earnings on Aug 19, 2025.

SRZN is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+11.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($187M) has a higher market cap than SRZN($74M). INBX YTD gains are higher at: -16.299 vs. SRZN (-39.791). INBX has higher annual earnings (EBITDA): 1.72B vs. SRZN (-25.06M). INBX has more cash in the bank: 196M vs. SRZN (31M). SRZN has less debt than INBX: SRZN (1.53M) vs INBX (1.84M). SRZN has higher revenues than INBX: SRZN (10M) vs INBX (1.57M).
INBXSRZNINBX / SRZN
Capitalization187M74M253%
EBITDA1.72B-25.06M-6,872%
Gain YTD-16.299-39.79141%
P/E Ratio0.11N/A-
Revenue1.57M10M16%
Total Cash196M31M632%
Total Debt1.84M1.53M120%
TECHNICAL ANALYSIS
Technical Analysis
INBXSRZN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 17 days ago
80%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 11 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESAB125.671.43
+1.15%
ESAB Corp
RLJ7.250.04
+0.55%
RLJ Lodging Trust
DIS112.53-0.96
-0.85%
Walt Disney Company (The)
SKYT9.09-0.24
-2.57%
SkyWater Technology
NVNO3.50-0.18
-4.89%
enVVeno Medical Corp

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-0.85%
AXON - INBX
48%
Loosely correlated
+1.08%
AKESF - INBX
45%
Loosely correlated
+0.72%
SNTI - INBX
39%
Loosely correlated
+5.01%
RAPT - INBX
38%
Loosely correlated
-0.49%
DNLI - INBX
38%
Loosely correlated
-1.35%
More

SRZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRZN has been loosely correlated with IRON. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SRZN jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRZN
1D Price
Change %
SRZN100%
+3.97%
IRON - SRZN
34%
Loosely correlated
+1.39%
INBX - SRZN
32%
Poorly correlated
-0.85%
ELDN - SRZN
32%
Poorly correlated
-6.15%
ATHE - SRZN
29%
Poorly correlated
+5.03%
ABCZF - SRZN
28%
Poorly correlated
N/A
More